Ritter Pharmaceuticals, Inc. Release: Andrew Ritter Named Finalist in LA Business Journal's Annual Healthcare Leadership Awards
4/24/2013 10:16:53 AM
More...
|
Ritter Pharmaceuticals, Inc. Release: Patient Survey: More Than 80% Forced to Change Lifestyles Due to Lactose Intolerance
4/17/2013 10:53:21 AM
More...
|
Ritter Pharmaceuticals, Inc. Encouraged by Meeting With FDA
3/20/2013 8:57:43 AM
More...
|
Ritter Pharmaceuticals, Inc. Names Larry Good, M.D. Chief Medical Officer
2/13/2013 9:50:34 AM
More...
|
Ritter Pharmaceuticals, Inc. Release: Survey: 75% of People With Lactose Intolerance Avoid Dairy Foods
1/30/2013 9:03:10 AM
More...
|
Ritter Pharmaceuticals, Inc. Release: Lactose Intolerance: Major Unmet Medical Need
1/7/2013 10:04:48 AM
More...
|
Ritter Pharmaceuticals, Inc.' Abstract on RP-G28's Phase 2 Trial Selected for Oral Presentation at Digestive Disease Week 2012
2/16/2012 8:20:32 AM
More...
|
Ritter Pharmaceuticals, Inc.' RP-G28 Improves Lactose Intolerance Symptoms and Lactose Digestion in Phase 2 Trial
1/5/2012 8:54:32 AM
More...
|
Ritter Pharmaceuticals, Inc. Appoints Robert H. Tidwell as Chief Business Officer
12/8/2011 9:46:53 AM
More...
|
Ritter Pharmaceuticals, Inc. Completes Phase 2 Clinical Study of RP-G28 for the Treatment of Lactose Intolerance
11/17/2011 7:35:21 AM
More...
|
|